AzTrials
AzTrials

PainNCT00873743

Analgesia and Antihyperalgesia of Tramadol and Acetaminophen Per Oral After Caesarean Section

An observational study of Pain and Cesarean Section, run by Medical University of Vienna at 1 site in Austria.

Suspended

Paused. Enrolment is on hold for now and may resume.

Official record
Search all trials

Trial summary

The aim of this study is to evaluate quality of patient-controlled peroral analgesia after cesarian section using the combination of tramadol and acetaminophen. Research hypothesis is that the combination reduces pain at leg rising more than tramadol alone. Read more about this study

Who is it for?
Ages 18 to 45 years, women onlyHealthy volunteers can take part
Conditions the study is for
Pain, Cesarean Section
How many people
120 participants
Where
1 siteAustria
Study dates
Oct 2008to Oct 2009
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 45 years
  • Women only
  • Healthy volunteers accepted
  • Adult

Study population: Female patients postoperatively after cesarian section

Who may be able to join

  • 18 and 45 years
  • ASA-Status 1-2
  • BMI 19-29, that are scheduled for planned caesarean section and have given written informed consent

Who cannot join

  • Allergies or hypersensitivities to evaluated drugs
  • History of pain syndrome
  • Substance abuse
  • Preeclampsia or eclampsia
  • Deviation from standardised surgical procedure
  • Treatment with magnesium sulfate
  • Renal or hepatic impairment and deviations from the standardized anaesthetic treatment

Trial locations and contacts

1 site in 1 country.

Austria1 site
  • Medical University Vienna

    Vienna, State of Vienna, 1080

Other trials in Austria

About this study

Official title: Postoperative Analgesia and Antihyperalgesia of Tramadol and Acetaminophen Per Oral After Caesarean Section -A Randomised Controlled Trial in Female O-Desmethyl 1 Metabolizers Identified by the Respective Gene-

The aim of this study is to evaluate quality of patient-controlled peroral analgesia after cesarian section using the combination of tramadol and acetaminophen. Research hypothesis is that the combination reduces pain at leg rising more than tramadol alone.

Read the detailed description

Caesarean section rate is growing in western countries (from 9% by 1980, to 12% by 1990 up to 22-24% in 2002)1.

Pain after Caesarean section involves 2 components, somatic pain from the wound and visceral pain from uterine contractions2. Different mechanisms underlie somatic and visceral pain transmission, at spinal and supraspinal levels, supporting different sensitivity to analgetics2. Pain at rest is usually well controlled by parenteral opioids, while pain induced by movements is less responsive to opioids, requesting higher doses with an increase of side effects3.

Beyond the concern of short term recovery, postoperative pain management has an impact on the risk of developing residual pain after surgery4. Following Caesarean section 18% of patients still suffer from pain 3 months after surgery. 12% still complain after 10 months and for 6% pain is a significant problem, interfering with quality of life and being present daily or almost daily5.

Central sensitization, clinically expressed as hyperalgesia and allodynia, not only contributes to postoperative pain perception, but also is associated with the presence of chronic pain state6.

Aside from tissue damage, the most striking risk factor for developing residual pain seems to be the level of immediate postoperative pain7.

From all published data, it is clear that opioids alone do not completely relieve pain after Caesarean section. Achieving effective acute pain control and minimizing side effects, is best possible by the combination of several analgetics acting through different mechanisms (so called balanced analgesia).8-11

Tramadol is an effective postoperative analgetic, combining mainly µ-opioid and monoaminerg actions with good clinical effect in treating somatic and visceral pain12,13. The postoperative use of tramadol after Caesarean is insufficiently evaluated. Studies evaluate a short period of 614 or 815 hours postoperatively. Metaanalysis sum up a mix of non-gynaecological and gynaecological data together. Edwards et al. 2002 used data from 7 unpublished randomized, double-blind, placebo controlled trials assessing tramadol and acetaminophen with dental, gynaecological and orthopaedic patients15. Moore et al. 199616 used 18 primary trials for data collection, from which only one had been published (Sunshine et al. 1992)14. Thus clear statement of tramadol after Caesarean section is not possible.

NSAID´s, widely used as additives for postoperative pain management, have the inconvenient of gastrointestinal side-effects, increased risk for bleeding and of being secreted in breast milk11. The product prescription of diclofenac, ibuprofen and ketoprufen clearly contraindicates its use by breast feeding women. There is little experience with the use of COXII-Inhibitors by breast feeding women as well. Therefore these drugs are not recommended for postoperative use after Caesarean Section11.

Adding acetaminophen to weak opioids increases the analgetic potency of the opioid component16 and is widely used in obstetrics 14,17. According to the product information acetaminophen is recommended for breast feeding women as no neonatal side-effects have been observed.

Laboratory studies with rats have shown that acetaminophen is able to prevent hyperalgesia and block spinal sensitisation induced by NMDA and Substance P18. The same has been demonstrated in a laboratory setting with tramadol, that is able to prevent and reverse hyperalgesic behaviour in rats19. Furthermore it has been shown that the combination of acetaminophen and tramadol is very effective in inhibiting the quantification of proinflammatory mediators (PGE2, TNFα) in cerebrospinal fluid (CSF) and in preventing the development of hyperalgesia20.

In a human pain model, it could be demonstrated, that combining the drugs enhances antihyperalgesia and leads to supra-additive analgesia21.

In a clinical setting, however, the combination of acetaminophen and tramadol and its effects on postoperative sensitisation and pain has not been evaluated.

Tramadol and acetaminophen are both available for oral administration22. Oral analgetic treatments with various drugs (such as ibuprofen, oxycodone-acetaminophen or metamizol) after Caesarean section have been shown of being superior in terms of patient satisfaction and analgesia compared with parenteral opioid and iv. PCA devices23-25. Parenteral narcotics in general are associated with nausea, vomiting, constipation, pruritus, respiratory depression and sedation. Additionally, PCA devices and their associated stands are cumbersome, which potentially could interfere with newborn infant care. Other drawbacks include the expense and the need for close patient supervision 26-28.

The oral combination of acetaminophen and tramadol in respect of pain control and postoperative sensitization after Caesarean section has not been evaluated yet.

1.2: Study objective: Study objective is to evaluate the analgetic and antihyperalgetic potency of oral tramadol and acetaminophen in combination and alone after Caesarean Section.

In this study the following RESEARCH HYPOTHESIS will be tested:

  • Combining tramadol with acetaminophen reduces pain atleg rising more than Tramadol alone
  • Combining tramadol with acetaminophen has a dose sparing effect on tramadol
  • Side-effects can be reduced by the combination
  • The combination reduces the area of Pin-Prick hyperalgesia surrounding the incision more than tramadol alone
Keywords
lower pain intensity with combination drug after cesarian section in first 48h postoperatively
Medical subject headings
Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT00873743
Study groupRoleWhat they receive
160 women after elective cesarian section
260 women after elective cesarian section

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. VAS-Score at leg rising

    Measured: 4h, 8h, 24h 48h postoperatively

Secondary outcomes (1)
  1. VAS-Score at rest, nausea, vomitus, sedation, general satisfaction

    Measured: 4h, 8,h, 24h, 48h postoperatively

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Apr 2009 (estimated)
  2. Study startOct 2008
  3. Primary completionMay 2009 (estimated)
  4. Study completionOct 2009 (estimated)

Why it stopped: Study was stopped because of ineffectiveness of one investigated Drug

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Time perspective
Prospective
Enrolment
120 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00873743
Sponsor's protocol ID
31121976-3
Other IDs
Tramal 50mg kapseln 17.688, Zaldiar 37,5mg/325mg
Status last verified
Apr 2009
First submitted
1 Apr 2009
Last updated
2 Apr 2009
Results posted
No
Data monitoring committee
Yes

Questions about this trial

What is this clinical trial studying?

An observational study of Pain and Cesarean Section, run by Medical University of Vienna at 1 site in Austria.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: paused, as of the sponsor's last update on 2 Apr 2009. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Austria. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

VAS-Score at leg rising (time frame: 4h, 8h, 24h 48h postoperatively). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Apr 2009.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in